GlyCosmos Portal

GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source	Last Updated
GlycoNAVI Proteins	December 11, 2024

Displaying entries **20151 - 20200** of **40384** in total

« First

‹ Prev

…

400

401

402

403

404

405

406

407

408

…

Next ›

Last »
PDB ID	UniProt ID ▼	Title	Descriptor
6UGY	P0DOX5	Crystal structure of the Fc fragment of anti-TNFa antibody infliximab (Remicade) in a primative orthorhombic crystal form, Lot C
6UGY	P0DOX5	Crystal structure of the Fc fragment of anti-TNFa antibody infliximab (Remicade) in a primative orthorhombic crystal form, Lot C
6X3I	P0DOX5	NNAS Fc mutant
7CZV	P0DOX5	S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B
7CZV	P0DOX5	S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B
6KA7	P0DOX5	The complex structure of Human IgG Fc and its binding Repebody
6UGX	P0DOX5	Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a primative orthorhombic crystal form, Lot A
6UGX	P0DOX5	Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a primative orthorhombic crystal form, Lot A
6YSC	P0DOX5	GLYCOSYLATED KNOB-HOLE/DUMMY FC FRAGMENT
5WAV	P0DOX5	Fc AbVance: Increasing our knowledge of antibody structural space to enable faster and better decision-making in antibody drug discovery.
5WAV	P0DOX5	Fc AbVance: Increasing our knowledge of antibody structural space to enable faster and better decision-making in antibody drug discovery.
6BKB	P0DOX5	Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3A
6BKB	P0DOX5	Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3A
6BKC	P0DOX5	Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3B
6BKC	P0DOX5	Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3B
6MSY	P0DOX5	Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement
6MSY	P0DOX5	Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement
6N35	P0DOX5	Anti-HIV-1 Fab 2G12 + Man1-2 re-refinement
6N35	P0DOX5	Anti-HIV-1 Fab 2G12 + Man1-2 re-refinement
6VSL	P0DOX5	Crystal structure of a human fucosylated IgG1 Fc expressed in tobacco plants (Nicotiana benthamiana)
6YTB	P0DOX5	GLYCOSYLATED KNOB/DUMMY-HOLE/DUMMY FC FRAGMENT
5Y56	P0DOX5	Fc mutant (K392D/K409D/D399K)
6IFJ	P0DOX5	Structure of bispecific Fc
6IQG	P0DOX5	X-ray crystal structure of Fc and peptide complex
6MU3	P0DOX5	Anti-HIV-1 Fab 2G12 + Man7 re-refinement
6MU3	P0DOX5	Anti-HIV-1 Fab 2G12 + Man7 re-refinement
6UGW	P0DOX5	Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered orthorhombic crystal form, Lot A
6UGW	P0DOX5	Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered orthorhombic crystal form, Lot A
1HZH	P0DOX5	CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN
1HZH	P0DOX5	CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN
3PGF	P0DOX5	Crystal structure of maltose bound MBP with a conformationally specific synthetic antigen binder (sAB)
3PGF	P0DOX5	Crystal structure of maltose bound MBP with a conformationally specific synthetic antigen binder (sAB)
4R2G	P0DOX5	Crystal Structure of PGT124 Fab bound to HIV-1 JRCSF gp120 core and to CD4	Surface protein gp160, T-cell surface glycoprotein CD4, PGT124 Heavy Chain, PGT124 Light Chain
4R2G	P0DOX5	Crystal Structure of PGT124 Fab bound to HIV-1 JRCSF gp120 core and to CD4	Surface protein gp160, T-cell surface glycoprotein CD4, PGT124 Heavy Chain, PGT124 Light Chain
5O4E	P0DOX5	Crystal structure of VEGF in complex with heterodimeric Fcab JanusCT6
5YC5	P0DOX5	Crystal structure of human IgG-Fc in complex with aglycan and optimized Fc gamma receptor IIIa
6N2X	P0DOX5	Anti-HIV-1 Fab 2G12 + Man9 re-refinement
6N2X	P0DOX5	Anti-HIV-1 Fab 2G12 + Man9 re-refinement
6V8Z	P0DOX5	VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure
6V8Z	P0DOX5	VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure
6VSZ	P0DOX5	Crystal structure of a human afucosylated IgG1 Fc expressed in tobacco plants (Nicotiana benthamiana)
6YT7	P0DOX5	GLYCOSYLATED KNOB/DUMMY-HOLE FC FRAGMENT
8DV1	P0DOX5	SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to linker variant of affinity matured ACE2 mimetic CVD432
8DV2	P0DOX5	SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to computationally engineered ACE2 mimetic CVD293
8GHR	P0DOX5	Structure of human ENPP1 in complex with variable heavy domain VH27.2
8W4L	P0DOX5	Crystal structure of closed conformation of human immunoglobulin Fc in presence of EndoSz
8W4M	P0DOX5	Crystal structure of open conformation of human immunoglobulin Fc in presence of EndoSz
8EDF	P0DOX5	Bovine Fab SKD in complex with Sars COV-2 receptor binding domain
8EDF	P0DOX5	Bovine Fab SKD in complex with Sars COV-2 receptor binding domain
9IIE	P0DOX5	Cryogenic Temperature Crystal Structure of Fc Fragment of Human IgG1 from Biosimilar VEGF-Trap

Download data in CSV format Download data in TSV format Download data in JSON format

Table Filtering

GlyTouCan

GlyComb

GlycoPOST

UniCarb-DR

LM-GlycoRepo

All Resources

Other Information

Tools

Search Tools

International Collaboration

Acknowledgements